Dermatology Times, March 2020 (Vol. 41, No. 3)

March 23, 2020

Rhinophyma is a disfiguring condition with deleterious psychosocial and functional consequences, and its pathogenesis remains unclear. Deborah S. Sarnoff, M.D., offers insight on its etiology, and treatment options in this article.

March 23, 2020

Although the fractional ablative CO2 laser is a first-line treatment for acne scarring, the potential for side effects from repetitive treatments leaves room for improvement with additive therapies, according to a recent review.

March 19, 2020

In this Cosmetic Conundrum article, Zoe Diana Draelos, M.D., discusses how cosmeceuticals can be modified to address the diurnal variation in skin needs that occur during the body's circadian rhythm.

March 18, 2020

Positive outcomes with an experimental vaccine provide hope for patients with stage IIB and IIC melanoma.

March 18, 2020

The 595 nm pulsed dye laser (PDL) may provide an effective option for nonvascular conditions, such as scars, acne and molluscum contagiosum, according to a recent review.

March 17, 2020

Adult patients with moderate-to-severe atopic dermatitis who were treated with systemic agents, including cyclosporine, azathioprine, mycophenolate mofetil, methotrexate or cyclophosphamide, reported a high level of disease-related burden despite those treatments, says a recent study.

March 17, 2020

Maximizing results and safety of aggressive resurfacing procedures requires painstaking postprocedural care, says Dallas-based plastic and reconstructive surgeon A. Jay Burns, M.D.

March 16, 2020

Unscrupulous skin lightening practices are becoming a problem in the United States, according to dermatologist Arianne Shadi Kourosh, M.D., MPH.

March 16, 2020

A study showing differences in baseline characteristics between responders to anti-tumor necrosis factor (anti-TNF) therapy and insufficient responders may be helpful to dermatologists as they consider treatment for patients with moderate-to-severe psoriasis, according to the investigators.

March 11, 2020

Topical ivermectin cream, 1% (Soolantra, Galderma) represents an advance in treatment for rosacea, offering superior efficacy and tolerability compared with previously available therapies, says Jeffrey S. Fromowitz, M.D., who spoke at the Orlando Dermatology Aesthetic & Clinical Conference.

March 10, 2020

In this Legal Eagle article, David J. Goldberg, M.D., J.D., discusses whether or not you can pay a patient to leave your practice.

March 09, 2020

Atopic dermatitis therapy is currently undergoing a revolution that promises to treat patients of all ages who are suffering from every aspect of the disease-from rashes, itch and sleep disturbances, to secondary effects, like anxiety and depression.

March 09, 2020

Though still considered controversial, several evolving treatment and management plans for primary cutaneous melanoma are making their way into the mainstream and challenging more traditional approaches.

March 09, 2020

New joint AAD-NPF guidelines consider the quality-of-life impact of pediatric psoriasis as well as comorbidity risks in this patient population.

March 09, 2020

Dermatologists should engage in collaborative efforts to guide pharmaceutical companies as they develop drugs needed for the continued excellence of the specialty.

January 10, 2020

December 19, 2019

Topical probiotics could promote a positive bacterial balance in the skin – similar to how oral probiotics increase diversity of flora in the gut – and may improve skin conditions, such as acne, say authors of a recent review.

October 29, 2019

Interleukin-29 (IL-29) is a newly discovered cytokine that has become the subject of increased research attention for its role in inflammation and inflammatory autoimmune disorders and therefore as a target for novel therapeutic development.